ArticleScientific reports2026

The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.

Héctor Frayde-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.